Nuclear protein IRF-1 (interferon regulatory factor 1) was earlier shown to bind to cis-acting regulatory elements present on interferon (IFN)-a/fi genes and some IFN-inducible genes. Here we show that in both human FS-4 and murine L929 cells, steady-state levels of IRF-1 mRNA were increased by treatment with tumor necrosis factor (TNF), interleukin 1 (IL-1), poly(I)-poly(C), or IFN-fi. IRF-1 mRNA induction was also demonstrated in cells treated with calcium ionophore A23187 or with phorbol 12-myristate 13-acetate, but not with epidermal growth factor, dibutyryl-cAMP, or the adenylate cyclase activator forskolin. To determine whether stimulation of IRF-1 mRNA levels correlates with IFN-f3 induction, we compared IRF-1 and IFN-.8 mRNA levels in cells exposed to various stimuli. In L929 cells, treatment with poly(I)-poly(C) under conditions that failed to induce significant levels of IFN-I3 mRNA led to a very low induction of IRF-1 mRNA, but "priming" cells with IFN prior to the addition of poly(I)-poly(C) greatly increased both IRF-1 and IFN-fi mRNAs. In FS-4 cells an increase in IFN-8 mRNA (examined by the polymerase chain reaction) was seen after treatment with TNF, IL-1, A23187, or poly(I) poly(C), but not with IFN-P3 epidermal growth factor, dibutyryl-cAMP, or forskolin. Thus, all treatments that increased steady-state levels of IFN-j3 mRNA also enhanced IRF-1 mRNA levels. However, treatment with IFN-,B, which caused a marked stimulation in IRF-1 mRNA, failed to produce a detectable increase in IFN-fJ mRNA. It appears that IRF-1 may be necessary but not sufficient for IFN-/8 induction. The ability of TNF and IL-1 to increase both IRF-1 and IFN-f8 mRNAs may be responsible for some similarities in the actions of TNF, IL-1, and the IFNs.
genes (1) (2) (3) . The regulatory region of the human IFN-p gene is composed of distinct functional domains, and inducibility by viruses or double-stranded RNA is thought to be regulated by the interaction of several trans-acting nuclear factors with these sequences (3) (4) (5) (6) (7) (8) (9) . Virus-induced transcriptional activation of the human IFN-,8 (10) or IFN-a (11) genes can be mediated by specific repetitive hexanucleotide sequences present within the enhancer region. A nuclear factor termed IRF-1 (interferon regulatory factor 1) was identified on the basis of its ability to bind to these hexameric sequences (5) . IRF-1, whose synthesis is strongly inducible by virus infection, acts as a positive transcription factor for the expression of IFN-a/,8 genes (12, 13) .
Recent observations suggest that regulatory mechanisms governing the expression of IFN-inducible genes partly overlap the mechanisms regulating the expression of the IFN-a/,3 genes themselves. This conclusion is based on the observations of similarities between the sequences controlling inducibility in IFN-a/,B genes and several IFN-induced genes (14) (15) (16) . In addition, it was shown that some IFN-induced genes are also inducible by viruses or double-stranded RNA (14, 15, 17) . In agreement with these findings, IRF-1 was shown to bind to regulatory elements in at least one group of IFNinduced genes, the class I major histocompatibility complex genes (12) . Furthermore, IRF-1 synthesis is induced not only by virus infection, but also by treatment with IFN (6) .
Other observations indicate that some actions of the IFNs can be mimicked by other cytokines or growth factors. For example, the synthesis of some proteins characteristically induced by the IFNs was also shown to be inducible by tumor necrosis factor (TNF) or interleukin 1 (IL-1) (18) (19) (20) (21) (22) or by growth factors (17, 23, 24) . Furthermore, IL-1 (25) or TNF (26) (27) (28) were shown to stimulate IFN-p synthesis in some cells. These observations led us to examine the ability of some cytokines, growth factors, and activators of secondmessenger pathways to increase IRF-1 mRNA levels in cultures of murine L929 and human FS-4 cells. We also compared the inducibility of IRF-1 and IFN-,B mRNAs by these treatments. We found that IRF-1 and IFN-f3 mRNAs are inducible by TNF, IL-1, and some activators of secondmessenger pathways. We conclude that induction of IRF-1 may be responsible for some IFN-like actions of TNF and IL-1. Induction of IRF-1 by TNF and IL-1 also may contribute to the ability of these cytokines to induce IFN-,B.
MATERIALS AND METHODS Materials. Nick-translation kits, DNase I, and proteinase K were from Boehringer Mannheim. Poly(I)-poly(C) was obtained from P-L Biochemicals. N6,02'-Dibutyryladenosine 3',5'-cyclic monophosphate (dibutyryl-cAMP), forskolin, phorbol 12-myristate 13-acetate (PMA), and calcium ionophore A23187 were from Sigma. A neutralizing monoclonal antibody to human TNF (29) (12) . The mRNA copy number was calculated as described (10 phore A23187 increased IRF-1 mRNA with delayed kinetics, with a peak reached only at 4 hr.
Comparison of IRF-1 and IFN-fi mRNA Levels After Different Treatments. If IRF-1 is necessary for IFN-f3 induction, then treatments that induce IFN-/3 mRNA should also increase IRF-1 mRNA. Infection of L929 cells with Newcastle disease virus led to an increase in both IRF-1 and IFN-,B mRNA levels (12) . In addition, the expression of IRF-1 in COS cells led to an induction of IFN-a and IFN-f3 (13) .
To gain more insight into the relationship between the induction of IRF-1 mRNA and that of IFN-/3 mRNA, we examined the effect of a double-stranded RNA, poly(I)poly-(C), in L929 cells. Exposure of L929 cells to poly(I)poly(C) led to no detectable increase in IFN-,3 mRNA and to a barely demonstrable increase in IRF-1 mRNA 1 hr after the addition of poly(I)-poly(C) to the cells (Fig. 3A) . This finding reflects the fact that poly(I)-poly(C) is a relatively weak inducer of IFN-,f in these cells (35) . Induction of IFN-f3 can be enhanced by "priming" cells with IFN prior to the addition of the inducer (35, 36) . hr. Thereafter both groups of cultures were exposed to poly(I)-poly-(C) (100 ,g/ml) in the presence of DEAE-dextran (100 ,ug/ml) for 1 hr (from 3 to 4 hr on the time scale shown). At the indicated times the cells were harvested and IRF-1 and IFN-,B mRNA levels (molecules per cell) were determined by S1 mapping. IFN-/3 mRNA in these cell extracts. Since amplification by PCR over a large number of cycles is not strictly linear (37), the degree of increase in mRNA concentration after TNF or IL-1 treatment may actually be greater than the increase in the radioactivity of the corresponding bands. To prove that the amplified IFN-,B cDNA was not in part or in whole due to contamination with genomic DNA, we carried out the PCR with the same RNA preparations while omitting the reversetranscription step (Fig. 4B Right) . No bands were discernible, proving a lack of contamination with genomic IFN-,f DNA.
Induction of IRF-1 and IFN-,B mRNAs was also analyzed in FS-4 cultures exposed to various activators of secondmessenger pathways, to poly(I)-poly(C), or to IFN-13. In general agreement with the results obtained in L929 cells, an increase in IRF-1 mRNA was seen after treatment with calcium ionophore A23187 or phorbol ester, but not after treatment with dibutyryl-cAMP or forskolin (Fig. 5A) . Unlike (38) , and in some cells TNF (26) (27) (28) Proc. Natl. Acad. Sci. USA 86 (1989) 9939 or IL-1 (25) was shown to induce IFN-/8. These observations suggest that TNF, IL-1, and IFNs share the ability to activate regulatory factors that drive the expression of the same cellular genes, including the IFN-a//3 genes themselves.
IRF-1 was recently identified as a positive transcription
factor regulating the expression of IFN-a/p genes (12, 13) .
Furthermore, IRF-1 was shown to bind to a sequence in the regulatory region of the murine H-2Dd gene, suggesting a role for IRF-1 in the-regulation of some IFN-inducible genes (12) . In the present study we tried to answer two major questions. IFNs-e.g., the genes for 2'-5' oligoadenylate sythetase (18) , class I and II major histocompatibility complex antigens (19, 20) , , and some other, incompletely identified gene products (21, 22) . On the other hand, no evidence for the stimulation of IRF-1 mRNA was seen with EGF ( Fig. 4A ).
Platelet-derived growth factor also failed to produce a significant stimulation of IRF-1 mRNA levels in both L929 and always correlate with IFN-,B induction is that negative regulatory factors also are likely to be involved in the control of IFN-p gene expression. A putative negative regulatory factor, IRF-2, has been identified and cloned (6) . The IRF-2 protein binds to the same nucleotide sequence element and also shares extensive sequence homology with IRF-1 in its DNA-binding portion. Although the exact role of IRF-2 in the control of IFN-/3 expression is still under study, its slower kinetics of induction by some agents and its ability to down-regulate the function of IRF-1 under some conditions suggest that it acts as a repressor.
